Ebglyss 250 mg/2 mL injection Images
Generic Name: lebrikizumab
This medication has been identified as Ebglyss 250 mg/2 mL injection. It is supplied by Eli Lilly and Company.
Ebglyss is used in the treatment of Atopic Dermatitis and belongs to the drug class interleukin inhibitors. Ebglyss 250 mg/2 mL injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Ebglyss
- Generic Name
- lebrikizumab
- Strength
- 250 mg/2 mL injection
- Availability
- Prescription only
- Drug Class
- Interleukin inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Eli Lilly and Company
- National Drug Code (NDC)
- multiple
See also:
More about Ebglyss (lebrikizumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (2)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: interleukin inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.